The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAura Egy Regulatory News (AURA)

Share Price Information for Aura Egy (AURA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.263%)
Open: 9.75
High: 9.75
Low: 9.75
Prev. Close: 9.75
AURA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

17 Mar 2021 07:45

RNS Number : 5421S
Aura Energy Limited
17 March 2021
 

17 March 2021

 

 

AURA ENERGY LIMITED

("Aura" or the "Company")

Results of Annual General Meeting

 

The Company wishes to advise that all Resolutions contained in the Notice of Meeting were carried by poll with the exception of Resolution 2 on Conditional Spill.

 

In accordance with ASX Listing rule 3.13.2 and Section 251AA(1) of the Corporations Act 2001, the following link provides information in relation to the proxy votes received for each Resolution considered by Members of the Company at the Annual General Meeting held today.

 

http://www.rns-pdf.londonstockexchange.com/rns/5421S_1-2021-3-17.pdf

 

Resolution 1 required 75% approval to be passed. This threshold has been achieved and these resolutions passed.

 

 

Aura Energy Limited

Peter Reeve (CEO)

 

SP Angel Corporate Finance LLP

(Nominated Advisor and Joint Broker)

Ewan Leggat

Caroline Rowe

 

WH Ireland Limited

(Joint Broker)

Adrian Hadden

James Sinclair-Ford

 

 

Yellow Jersey PR Limited

Felicity Winkles

Joe Burgess

 

Telephone: +61 (3) 9516 6500

info@auraenergy.com.au

 

Telephone: +44 (0) 203 470 0470

 

 

 

 

 

Telephone: +44 (0) 207 220 1666

 

 

 

 

 

Telephone: +44 (0) 7769 325 254

 

 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

Martin Rogers - Non-Executive Chairman

The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Martin Frederick Rogers, aged 40:

 Current directorships and/or partnerships:

Former directorships and/or partnerships (within the last five years):

 

KTM Ventures Innovation Fund LP

SpringCapital

Bitcoin Access

 

Independent Reserve

Identitii

Actinogen Medical

OncoSil Medical

 

 

As at the date of this announcement, Mr. Rogers does not hold any shares in the Company although following the issue of shares and options as proposed and passed at the AGM, Mr. Rogers will hold 50,000,000 shares on a pre-Consolidation basis, or 3,846,554 shares on a post-Consolidation basis. Mr. Rogers will also hold 200,000,000 options on a pre-Consolidation basis, or 15,384,616 options on a post-Consolidation basis.

These options will be exercisable at A$0.004 each on a pre-Consolidation basis, or A$0.052 each (on a post-Consolidation basis), on or before 30 June 2024.

Peter Ward - Non-Executive Director

 The following information is disclosed pursuant to Rule 17 and Schedule Two paragraph (g) of the AIM Rules for Companies in relation to Peter Daniel Ward, aged 51:

No current directorships or previous directorships within the last five years are held by Mr. Ward.

As at the date of this announcement, Mr. Ward holds 3,000,000 shares in the Company although following the issue of shares and options as proposed and passed at the AGM, Mr. Ward will hold 28,000,000 shares on a pre-Consolidation basis, or 2,153,846 shares on a post-Consolidation basis. Mr. Ward will also hold 75,000,000 options on a pre-Consolidation basis, or 5,769,230 options on a post-Consolidation basis.

These options will be exercisable at A$0.004 each on a pre-Consolidation basis, or A$0.052 each (on a post-Consolidation basis), on or before 30 June 2024.

There are no further disclosures required under Schedule 2(g) of the AIM Rules for Companies. 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGDKOBQOBKKNND
Date   Source Headline
31st Mar 20239:00 amRNSPrice Monitoring Extension
31st Mar 20238:17 amRNSASX Trading Halt
31st Mar 20238:01 amRNSTotal Voting Rights
29th Mar 20237:01 amRNSEnhanced Feasibility Study Investor Webinar
29th Mar 20237:00 amRNSEnhanced Feasibility Study - Tiris Uranium Project
24th Mar 20237:00 amRNSHolding(s) in Company
23rd Mar 20237:03 amRNSHolding(s) in Company
20th Mar 20237:55 amRNSIssue of Equity
16th Mar 20238:09 amRNSHalf-year Report
10th Mar 20237:00 amRNSRelease of Shares from Voluntary Escrow
6th Mar 20237:00 amRNSIssue of Equity
28th Feb 20237:00 amRNSTotal Voting Rights
20th Feb 20237:00 amRNSIssue of Equity
14th Feb 20237:00 amRNSMajor Resource Upgrade at Aura’s Tiris Project
10th Feb 20237:00 amRNSHolding(s) in Company
10th Feb 20237:00 amRNSHolding(s) in Company
3rd Feb 20237:00 amRNSIssue of Equity
1st Feb 20237:00 amRNSTransformational Agreements finalised for Tiris
31st Jan 20237:45 amRNSTotal Voting Rights
31st Jan 20237:18 amRNSQuarterly Report for the Period Ending 31 Dec 2022
23rd Jan 20239:05 amRNSSecond Price Monitoring Extn
23rd Jan 20239:00 amRNSPrice Monitoring Extension
13th Jan 20237:00 amRNSIssue of Equity
12th Jan 20237:24 amRNSDirector Dealing
30th Dec 20227:00 amRNSTotal Voting Rights
22nd Dec 20228:28 amRNSAppendix 3Y
21st Dec 20227:00 amRNSAdmission of Loan Funded Shares
7th Dec 20227:34 amRNSIssue of Equity
6th Dec 20227:51 amRNSTiris Project Uranium Product
2nd Dec 20227:25 amRNSHolding(s) in Company
1st Dec 20228:18 amRNSHolding(s) in Company
30th Nov 20227:00 amRNSTotal Voting Rights
29th Nov 20229:21 amRNSResults of Annual General Meeting
29th Nov 20227:00 amRNSInvestor Presentation
18th Nov 20227:44 amRNSInvestor Presentation
18th Nov 20227:41 amRNSIssue of Equity
4th Nov 20227:00 amRNSIssue of Equity
31st Oct 20227:02 amRNSTotal Voting Rights
31st Oct 20227:01 amRNSNotice of Annual General Meeting
31st Oct 20227:00 amRNSQuarterly Report for the Period Ending 30 Sept 22
27th Oct 20229:10 amRNSHolding(s) in Company
25th Oct 20228:58 amRNSHolding(s) in Company
20th Oct 20228:48 amRNSNew Investor Presentation
19th Oct 20228:25 amRNSAura Continues to Advance Tiris Uranium Project
18th Oct 20227:00 amRNSAppendix 3X
14th Oct 20227:00 amRNSIssue of Equity
6th Oct 202210:04 amRNSRelated Party Transaction
4th Oct 20227:04 amRNSIssue of Equity
4th Oct 20227:00 amRNSTotal Voting Rights
30th Sep 202211:09 amRNS2022 Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.